Home/Filings/4/0001453814-19-000151
4//SEC Filing

Larsen Jill 4

Accession 0001453814-19-000151

CIK 0001453814other

Filed

Oct 27, 8:00 PM ET

Accepted

Oct 28, 4:38 PM ET

Size

15.1 KB

Accession

0001453814-19-000151

Insider Transaction Report

Form 4
Period: 2019-10-28
Larsen Jill
EVP, Human Resources
Transactions
  • Disposition to Issuer

    Stock Options (right to buy)

    2019-10-2817,2000 total
    Exercise: $72.51Exp: 2028-04-23Common Stock (17,200 underlying)
  • Disposition to Issuer

    Common Stock

    2019-10-28$92.25/sh45,555$4,202,4490 total
  • Disposition to Issuer

    Restricted Stock Units (Performance-Related)

    2019-10-2810,3430 total
    Exercise: $0.00Common Stock (10,343 underlying)
  • Disposition to Issuer

    Restricted Stock Units (Performance Related)

    2019-10-2819,9540 total
    Exercise: $0.00Common Stock (19,954 underlying)
Footnotes (8)
  • [F1]On October 28, 2019, pursuant to the Agreement and Plan of Merger, dated as of June 11, 2019, by and among Dassault Systemes SE ("DS"), Dassault Systemes Americas Corp., a Delaware corporation ("Parent"), 3DS Acquisition 6 Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), and Medidata Solutions, Inc., a Delaware corporation (the "Issuer"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent and an indirect wholly-owned subsidiary of DS (the "Merger"). Pursuant to the separation agreement by and between the reporting person and the Issuer, dated October 25, 2019, each of the reporting person's shares of restricted stock will be deemed a Non-Employee RSA under the terms of the Merger Agreement.
  • [F2]Disposed of pursuant to the Merger Agreement and by virtue of the Merger, in which each share of Medidata common stock, par value $0.01 per share ("Issuer Common Stock"), issued and outstanding immediately prior to the completion of the Merger (other than restricted share awards held by continuing employees) was converted into the right to receive $92.25 in cash and without interest (the "Merger Consideration"). Such number of shares includes shares issued to the reporting person upon accelerated vesting of the reporting person's RSAs and Issuer PBRSUs (referred to below) immediately prior to the effective time of the Merger.
  • [F3]Included are 174 shares which were purchased pursuant to the terms of the Medidata Solutions, Inc. Employee Stock Purchase Plan on June 30, 2019.
  • [F4]Pursuant to the Merger Agreement and by virtue of the Merger, each option to purchase Issuer Common Stock will be cancelled and converted into the right to receive an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such option multiplied by (2) the excess, if any, of $92.25 per share over the exercise price per share under such option.
  • [F5]The options vested as to 25% of the shares on April 23, 2019 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months.
  • [F6]Pursuant to the separation agreement by and between the reporting person and the Issuer, dated October 25, 2019, each of the reporting person's performance-based restricted stock units will be deemed a Non-Employee PSU under the terms of the Merger Agreement and will be cancelled and converted into the right to receive an amount in cash equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such PSU based on the attainment of the applicable performance metrics as determined by the issuer's Compensation committee multiplied by (2) $92.25 per share.
  • [F7]Award of PBRSUs granted under the 2017 LTIP on April 23, 2018. The number of PBRSUs represented a target amount. Each PBRSU represented a contingent right to receive 0-200% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2020, and (ii) 50% based on the Company's GAAP Net Income attainment for the three years ending December 31, 2020. The shares would have vested immediately upon being earned.
  • [F8]Award of PBRSUs granted under the 2017 LTIP on February 12, 2019. The number of PBRSUs represented a target amount. Each PBRSU represented a contingent right to receive 0-225% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2021, and (ii) 50% based on the Company's revenue attainment for the three years ending December 31, 2021. The shares would have vested immediately upon being earned.

Issuer

Medidata Solutions, Inc.

CIK 0001453814

Entity typeother

Related Parties

1
  • filerCIK 0001738092

Filing Metadata

Form type
4
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 4:38 PM ET
Size
15.1 KB